Form 4: LENSAR Director Gary Winer Receives RSU Grant

Director Gary M. Winer was granted 17,421 restricted stock units as part of LENSAR, Inc.'s non-employee director compensation program.

Summary

• Director Gary M. Winer acquired 17,421 restricted stock units (RSUs) on June 3, 2026.
• The grant is part of the company's standard non-employee director compensation program.
• Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock.
• Following this transaction, the director's total beneficial ownership is 105,635 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial strategy.

Positives

• The grant aligns director interests with long-term shareholder value through equity-based compensation.

Negatives

• The issuance of RSUs results in minor dilution to existing shareholders upon vesting.

Risks

• Vesting is contingent upon the director's continued service to the company through June 3, 2027.

Future Outlook

The RSUs vest in full on June 3, 2027, subject to continued service, or earlier upon specific events such as a change in control, death, or disability.

Industry Context

StockSavvy.ai notes that equity-based compensation for non-employee directors is a standard corporate governance practice in the medical device and technology sectors to ensure board alignment with company performance.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices for small-cap medical technology companies.

Corporate Governance

Stakeholder Impact

• Minor dilution for existing shareholders upon future vesting.

Next Steps

• Vesting of RSUs on June 3, 2027.

Key Dates

Keywords

LENSAR, LNSR, Director Compensation, Restricted Stock Units, Insider Transaction, Equity Grant